Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Burch

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
Journal of Medicinal Chemistry|January 18, 2014
Back pocket flexibility provides group II p21-activated kinase (PAK) selectivity for type I 1/2 kinase inhibitorsSteven T Staben, Jianwen A Feng, Karen Lyle, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2013
Structure-based design and synthesis of potent benzothiazole inhibitors of interleukin-2 inducible T cell kinase (ITK)Colin H MacKinnon, Kevin Lau, Jason D Burch, et al.
Science Signaling|December 3, 2015
Inhibition of the kinase ITK in a mouse model of asthma reduces cell death and fails to inhibit the inflammatory responseYonglian Sun, Ivan Peng, Joshua D Webster, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2014
Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV virusesBernard Côté, Jason D Burch, Ernest Asante-Appiah, et al.
Journal of Medicinal Chemistry|June 26, 2018
Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing KinaseNicole Blaquiere, Georgette M Castanedo, Jason D Burch, et al.
Radiation Research|March 25, 2004
A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: objectives, design and methodsValentin A Stezhko, Elena E Buglova, Larissa I Danilova, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
Journal of Medicinal Chemistry|January 18, 2014
Back pocket flexibility provides group II p21-activated kinase (PAK) selectivity for type I 1/2 kinase inhibitorsSteven T Staben, Jianwen A Feng, Karen Lyle, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2013
Structure-based design and synthesis of potent benzothiazole inhibitors of interleukin-2 inducible T cell kinase (ITK)Colin H MacKinnon, Kevin Lau, Jason D Burch, et al.
Science Signaling|December 3, 2015
Inhibition of the kinase ITK in a mouse model of asthma reduces cell death and fails to inhibit the inflammatory responseYonglian Sun, Ivan Peng, Joshua D Webster, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2014
Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV virusesBernard Côté, Jason D Burch, Ernest Asante-Appiah, et al.
Journal of Medicinal Chemistry|June 26, 2018
Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing KinaseNicole Blaquiere, Georgette M Castanedo, Jason D Burch, et al.
Radiation Research|March 25, 2004
A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: objectives, design and methodsValentin A Stezhko, Elena E Buglova, Larissa I Danilova, et al.
Pageof 11